SAN FRANCISCO (PRWEB) January 05, 2018
uBiome will participate in the 36th Annual JP Morgan Healthcare Conference on Monday, Jan. 8th at the St. Regis Hotel San Francisco. Dr. Jessica Richman, co-founder and CEO of uBiome, will present in a session scheduled for 1:45 p.m. PST / 4:45 p.m. EST.
The 90-minute event will be moderated by journalist David Ewing Duncan and will commence with a keynote address from Aetna Health CEO, Jonathan Bush. Dr. Richman will be joined by Dr. Michael Nova, chief innovation officer at Pathway Genomics. The panel discussion will focus on the challenges of data generation and collection as well as the opportunities to apply it and integrate it into daily life.
Dr. Richman and the uBiome executive team will also host a private reception at the Warwick Hotel at 4:30 p.m. PST following the panel discussion.
Founded in 2012, uBiome is the world’s leading microbial genomics company with a mission to explore important research questions about the microbiome and develop reliable, accurate products and services, focused on the microbiome. uBiome is funded by Y Combinator, Andreessen Horowitz, 8VC and other leading investors. uBiome’s mission is to transform the science of the microbiome into useful products and services that improve people’s lives.
Jessica Richman, PhD